S.Biomedics

304360 · KOSDAQ

Public Market Listing

304360KOSDAQ

KOSDAQ primary exchange listing

Live quotes, historical charts, and market capitalization for S.Biomedics are available on Yahoo Finance.

View quote & market cap on Yahoo Finance ↗

External market data link · No third-party exchange redistribution

Assets

(2 total)
2Total Assets
0Approved
0Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
Showing 2 of 2 assets
Target & Modality
Phase 1/2
No discrete molecular targetCell therapy
Atherosclerotic Cardiovascular Disease
Phase 1/2
dopaminergic neuron replacementCell therapy
Parkinson's Disease

Upcoming events

No upcoming trial completions or earnings dates on record for this company's assets.

Financial reports

Annual history (2 years)

PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2024-FY$12M——$6.0Mreport ↗
View 1 more year
PeriodRevenueR&DCash & equiv.Net loss / qtrFiling
2023-FY$10M——$4.6Mreport ↗